For Advanced Lung Cancer, Immune Therapy Plus Chemo Prolongs Survival | Latest News RSS feed

For Advanced Lung Cancer, Immune Therapy Plus Chemo Prolongs Survival - Latest News


For advanced lung cancer, immune therapy plus chemo prolongs survival

Stefanie Joho, 27, in Penn Valley, Pennsylvania, last spring, was treated with Merck's Keytruda for advanced colon cancer. A new study shows that the immunotherapy drug, when combined with chemotherap... read more

New hope for lung cancer patients Study: Immunotherapy plus chemo prolongs survival

Patients with newly diagnosed advanced lung cancer who received an immunotherapy drug plus ... therapy group who were alive and whose disease had not gotten worse at a year was about 34 percent, about ... read more

Immune therapy scores big win against lung cancer in study

Another study found that an immunotherapy combo — the Bristol-Myers Squibb drugs Opdivo and Yervoy — worked better than chemo for delaying the time until cancer worsened in advanced lung ... survival, ... read more

Looking for another news?


There's More Good News About Immune Therapies for Cancer

There has been welcome excitement in the cancer field lately ... been approved since 2011 to treat advanced melanoma and have dramatically improved overall survival; the immune-based treatment is so e... read more

Jetpack

Lung cancer patients live longer with immune therapy

The odds of survival ... the study had an advanced stage of non-squamous non-small-cell lung cancer. The immune-activating drug was a checkpoint inhibitor called pembrolizumab, or Keytruda, made by Me... read more

For advanced lung cancer, immune therapy plus chemo prolongs survival

Patients with newly diagnosed advanced lung cancer who received an immunotherapy drug plus standard chemotherapy lived significantly longer than those who got chemo alone, according to a new study tha... read more

Immune therapy scores big win against lung cancer in study

For the first time, a treatment that boosts the immune system greatly improved survival ... chemo for the most common form of advanced lung cancer, but doctors have been leery to use it because that w... read more

Immune therapy scores win against lung cancer

Another study found that an immunotherapy combo — the Bristol-Myers Squibb drugs Opdivo and Yervoy — worked better than chemo for delaying the time until cancer worsened in advanced lung ... survival, ... read more



FeedsRSS Created by. Full RSS Feed | Privacy Policy | Contact Us